Community Research and Development Information Service - CORDIS

  • European Commission
  • CORDIS
  • Publications
  • Final Report - TB-DRUG OLIGOCOLOR (Development of a molecular platform for the simultaneous detection of Mycobacterium tuberculosis resistance to rifampicin and fluoroquinolones)
FP6

Final Report - TB-DRUG OLIGOCOLOR (Development of a molecular platform for the simultaneous detection of Mycobacterium tuberculosis resistance to rifampicin and fluoroquinolones)

Project ID: 516028
Funded under: FP6-LIFESCIHEALTH

Abstract

This is the final report for the TB-DRUG OLIGOCOLOR project which received funding under the European Commission's Sixth Framework Programme (FP6). Its main aim was to address the problem of Multi-drug resistant tuberculosis (MDR-TB) through the development of a versatile and user-friendly molecular platform for the identification of Mycobacterium tuberculosis and the simultaneous detection of resistance to key anti-tuberculosis agents directly in clinical specimens or liquid cultures.

The report begins with stating the aim of the project and then covers its principal objectives. It goes on with the contractors involved. The work performed, as well as the results achieved are also stated. The report concludes with the impact of the project.

Download application/zip (1296840)

Related information

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top